Atlas FDA

ADVIA Chemistry (Syva Onboard) Theophylline_2 (THEO_2) Reagent is for in vitro diagnostic use in the quantitative analys

FDA device recall Z-2299-2016 · posted 2016-07-28 · Terminated

Recall details

Recalling firm
Siemens Healthcare Diagnostics, Inc.
Reason for recall
Siemens Healthcare Diagnostics has confirmed the Syva EMIT 2000 Theophylline reagent lot G3, when run on a Beckman AU Clinical Chemistry System, and the ADVIA Chemistry Theophylline_2 (THEO_2) reagent lot 334018, may exhibit increased imprecision for commercially available Bio-Rad Liquichek TDM Quality Control Levels and patient samples
Action taken
Siemens Healthcare Diagnostics mailed a letter to customers on June 17, 2016, asking that they discontinue use of and discard the affected kit lots identified in the recall notification letter. Customers were also asked to complete and return the Field Correction Effectiveness Check/Product Replacement Form that was mailed with the Recall Notification Letter.
Root cause
Process control
Status
Terminated
Product code
KLS
Quantity affected
658 units
Distribution
Distributed to: CA, CT, DE, FL, GA, IA, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NM, NY, OH, OK, PA, TN, VA, WA
Date initiated
2016-06-17
Date posted
2016-07-28
Date terminated
2017-03-15
Location
Newark, DE

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
EMIT(R) 2000 THEOPHYLLINE ASSAY/CALIBRATORS (K913123)Syva Co.1991-09-19